Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Thomson Reuters
TRI
$42.8B
| $14.7M | 0.03% |
205,439
-590,289
| -74% | -$46M |
|
602
Sarepta Therapeutics
SRPT
$1.57B
| $14.6M | 0.03% |
149,744
-7,883
| -5% | -$901K |
|
603
Workiva
WK
$3.36B
| $14.6M | 0.03% |
451,887
+166,972
| +59% | +$6.94M |
|
604
PUT
Thermo Fisher Scientific
TMO
$213B
| $14.6M | 0.03% |
51,400
+33,500
| +187% | +$10.6M |
|
605
AtriCure
ATRC
$1.92B
| $14.6M | 0.03% |
433,193
-47,745
| -10% | -$1.72M |
|
606
CALL
State Street SPDR S&P Retail ETF
XRT
$449M
| $14.5M | 0.03% |
487,200
+121,900
| +33% | +$4.93M |
|
|
HOLX
607
DELISTED
Hologic
HOLX
| $14.5M | 0.03% |
413,257
-685,975
| -62% | -$32.7M |
|
608
Gaotu Techedu
GOTU
$434M
| $14.5M | 0.03% |
342,190
+278,838
| +440% | +$10.3M |
|
609
Iron Mountain
IRM
$36.4B
| $14.5M | 0.03% |
+607,484
| New | +$18.4M |
|
610
Philips
PHG
$25.7B
| $14.5M | 0.03% |
452,864
+117,548
| +35% | +$4.16M |
|
|
KLR.WS
611
CALL
DELISTED
Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share
KLR.WS
| $14.4M | 0.03% |
1,975,200
+1,675,200
| +558% | +$1.75M |
|
612
Sysco
SYY
$40.8B
| $14.4M | 0.03% |
315,665
+310,132
| +5,605% | +$21.5M |
|
|
CCXI
613
DELISTED
ChemoCentryx, Inc.
CCXI
| $14.3M | 0.03% |
355,231
-19,753
| -5% | -$839K |
|
614
Insperity
NSP
$1.93B
| $14.2M | 0.03% |
381,980
+365,330
| +2,194% | +$25.9M |
|
615
Dolby
DLB
$5.51B
| $14.2M | 0.03% |
262,299
+208,143
| +384% | +$13.6M |
|
|
AXNX
616
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.2M | 0.03% |
558,696
-1,376,442
| -71% | -$40.9M |
|
|
NBL
617
DELISTED
Noble Energy, Inc.
NBL
| $14.2M | 0.03% |
2,348,354
+2,300,088
| +4,765% | +$36.9M |
|
618
DraftKings
DKNG
$11.6B
| $14.1M | 0.03% |
1,146,118
+1,031,118
| +897% | +$14.8M |
|
619
CALL
JD.com
JD
$44.6B
| $14.1M | 0.03% |
348,800
+102,100
| +41% | +$4.08M |
|
|
SCVX.U
620
DELISTED
SCVX Corp. Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and on
SCVX.U
| $14.1M | 0.03% |
+1,414,300
| New | +$14.4M |
|
|
HPP
621
Hudson Pacific Properties
HPP
$747M
| $14.1M | 0.03% |
79,163
+4,284
| +6% | +$979K |
|
|
RP
622
DELISTED
RealPage, Inc.
RP
| $14M | 0.03% |
265,327
-235,878
| -47% | -$13.4M |
|
623
Rapid7
RPD
$645M
| $14M | 0.03% |
323,248
+158,478
| +96% | +$8.31M |
|
624
lululemon athletica
LULU
$13.5B
| $14M | 0.03% |
73,712
-95,400
| -56% | -$21.3M |
|
625
Sinclair Inc
SBGI
$992M
| $14M | 0.03% |
867,614
+344,992
| +66% | +$8.97M |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.